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Dengue virus infection induces a dramatic expansion of B cell plasmablasts. In this issue, Kwissa et al. (2014)
begin with transcriptomic analysis and then integrate studies in human clinical samples, nonhuman primates,
and coculture of primary human cells to identify a role for CD14+CD16+monocytes in generating plasmablast
responses during dengue virus infection.Dengue virus (DENV) continues to expand
as a major global health problem, with up
to 100 million dengue cases per year. The
four DENV serotypes (DENV1–4) are
transmitted by Aedes mosquitoes and
can result in a self-limiting, but debili-
tating, acute febrile illness (dengue fever)
or the more severe and potentially life-
threatening plasma leakage syndrome,
dengue hemorrhagic fever/dengue shock
syndrome. The primary risk factor for
developing severe disease is a secondary
infection with a different DENV serotype
than that causing the previous infection.
During acute DENV infection, a dramatic
expansion of plasmablasts occurs
(Wrammert et al., 2012; Zompi et al.,
2012). However, it is not known what fac-
tors play a role in this expansion. During
secondary DENV infection, these plasma-
blasts demonstrate a greater cross-reac-
tive response to DENV serotype(s) from
a previous infection than to the current
infecting serotype (Zompi et al., 2012).
It is thought that poorly neutralizing
serotype-cross-reactive antibodies can
enhance viral uptake through Fcg recep-
tors found on DENV target cells such as
macrophages and monocytes through
the mechanism of antibody-dependent
enhancement, which, along with cross-
reactive T cells and host genetic factors,
contributes to dengue disease severity.
However, the antibody and T cell
response can also play a protective role.
What tips the balance of the adaptive
immune response toward protection
versus pathogenesis is an area of active
investigation. In addition, it is not well un-
derstood which innate immune factors
contribute to control of viral load and dis-
ease severity.
In this issue of Cell Host & Microbe,
Kwissa et al. (2014) demonstrate how a
particular subset ofmonocytesmodulateshumoral responses during DENV infection
and thus unveil an important link between
the innate and adaptive immune
response. The authors utilize an inte-
grated systemsbiology approach inwhich
they combine results from studies in
human populations, nonhuman primates,
and in vitro analyses. First, they performed
transcriptomic analysis of samples from
Thai patients with either dengue fever or
dengue hemorrhagic fever. Transcrip-
tional signatures from these patients
during DENV infection correlated with
viral load and duration of illness, but not
disease severity—likely because the
study population did not include patients
with the most severe disease, dengue
shock syndrome. Previous reports have
associated changes in transcriptional pro-
file in dengue with the occurrence of
shock (Loke et al., 2010; Simmons et al.,
2007). Dengue patients experience high
viral load early after symptom onset;
DENV viremia decreases over the course
of illness so that samples taken at later
time points (R6 days) have low viral
load. Kwissa et al. (2014) conducted par-
allel analyses to evaluate gene expression
signatures in patients with high versus low
viral load and in samples collected early
versus late after symptom onset, and
overall they observed similar patterns in
samples with high viral load early in dis-
ease versus low viral load late in disease
progression. These findings are consis-
tent with previous studies in which gene
expression patterns exhibited temporal
changes over the course of illness (Popper
et al., 2012; Sun et al., 2013). Interestingly,
when Kwissa et al. (2014) focused only on
early timepoints post-symptomonset and
compared transcriptomic analysis in
patients with high or low viral load, they
found that viral load can influence gene
expression patterns independently ofCell Host & Mictime post-onset of illness, an observation
worthy of future study.
Samples with high viremia and/or
collected early after symptom onset
positively correlated with innate immune
responses associated with type I inter-
feron genes, whereas genes involved in
cell cycle, proliferation, and metabolism
correlated with lower viremia and later
stages of illness. Gene set enrichment
analysis detected genes associated with
monocytes, dendritic cells (DCs), and
macrophages in patients with high viremia
early in illness, whereas genes related to
natural killer cells, B cells, and CD4+ and
CD8+ T cells were associated with low
viremia later in the course of disease.
Thus, samples with high viremia from
early after symptom onset expressed
genes associated with innate immune
sensing of viruses and inflammatory re-
sponses to viral infection.
Kwissa et al. (2014) next examined
alterations in blood cells during acute
DENV infection and found an increased
frequency of monocytes and a reduction
in the proportion and absolute number
of a classical dendritic cell subset,
BDCA-1+ mDC-1 cells, especially in
patients with high viral load at early stages
of illness. This suggests that changes
within the peripheral bloodmay be related
to changes within the monocyte compart-
ment. Monocytes are the predominant
target for DENV infection in peripheral
blood mononuclear cells, and monocyte
activation has been implicated in DENV
pathogenesis (Durbinet al., 2008). Expres-
sion of the surface markers CD14 and
CD16 divides monocytes into three sub-
sets that display distinct ligand sensing
and cytokine/chemokine secretion pat-
terns: ‘‘classical’’ CD14+CD16, ‘‘inter-
mediate’’ CD14+CD16+, and ‘‘nonclas-
sical’’ CD14dimCD162+ monocytes (Wongrobe 16, July 9, 2014 ª2014 Elsevier Inc. 7
Figure 1. Identification of CD14+CD16+ Monocytes Involved in Plamablast Differentiation
CD14+CD16+ monocytes increase in humans and nonhuman primates following DENV infection. This monocyte population migrates to the lymph node and
expresses markers of subcapsular sinus macrophages, which are capable of activating antigen-specific B cells. CD14+CD16+ monocytes stimulate plasmablast
formation in vitro, driven by BAFF, APRIL, and IL-10. Illustrated by Sara Watson.
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Previewset al., 2011). Kwissa et al. (2014) found
genes associated with the CD14+CD16+
monocyte subset to be enriched in pa-
tients with high viral load/early disease
stage when monocyte-specific data sets
were used to analyze the whole-blood
transcriptome. These data were con-
firmed when monocyte populations were
evaluated via flow cytometry in both hu-
mans and a nonhuman primate model of
DENV infection. Nonhuman primates in-
fected with DENV demonstrated an in-
crease in CD14+CD16+ monocytes in pe-
ripheral blood between days 1 and 3
postinfection, and these cells were found
in the lymph nodes by day 3. In addition,
DENV infection of CD14+ monocytes
from healthy human donors increased
the frequency of CD14+CD16+ mono-
cytes. These DENV-infected monocytes
secreted MCP-1 (CCL-2), IP-10 (CXCL-
10), interleukin-6 (IL-6), IL-8, and IL-10,
similar to the pattern of cytokine and
chemokine secretion observed in the
plasmaofpatientswith high viral loadearly
in disease. These factors were previously
shown to be associated with CD14+
CD16+ monocytes (Wong et al., 2011).
Taken together, these data provide strong8 Cell Host & Microbe 16, July 9, 2014 ª2014evidence that DENV infection results in
increased frequency of CD14+CD16+
monocytes and suggest that they may
play a role in shaping the immune
response to DENV.
Further evaluation of DENV-infected
nonhuman primates indicated that CD14+
CD16+ monocytes express CD163 and
CD169, markers of tissue subcapsular
sinus macrophages. Subcapsular sinus
macrophages localize to the subcapsular
region of the lymph node and phagocy-
tose viruses and stimulate virus-specific
B cell responses (Junt et al., 2007). To
evaluate the ability of the CD14+CD16+
monocyte population to stimulate DENV-
specific B cell responses, Kwissa et al.
(2014) cocultured DENV-infected CD14+
CD16+ monocytes with autologous B
cells. DENV-infectedCD14+CD16+mono-
cytes stimulated resting B cells to differ-
entiate into CD272+CD382+ plasmablasts
that secreted immunoglobulin M (IgM)
and IgG. Further analysis of the in vitro
coculture system identified the B cell-
modulating cytokines BAFF, APRIL,
and IL-10, but not IL-6, as potential mech-
anisms by which this monocyte popula-
tion stimulates plasmablast formation.Elsevier Inc.Furthermore, expression of genes encod-
ing BAFF and APRIL was increased in
dengue patients with high viral load early
in disease progression. These data
suggest that early during DENV infection,
monocytes differentiate into CD14+
CD16+ monocytes and migrate to drain-
ing lymph nodes where they may
encounter and activate antigen-specific
memory B cells.
In summary, Kwissa et al. (2014) utilized
an elegant approach integrating immuno-
profiling of DENV-infected human clinical
samples with studies in nonhuman pri-
mates and in vitro coculture systems to
identify a monocyte subset that modu-
lates humoral responses (Figure 1). These
novel data show that following DENV
infection, CD14+CD16+ monocytes in-
crease in the peripheral blood of both
humans and nonhuman primates and
then localize to the lymph nodes. Whether
the increase in CD14+CD16+ monocytes
is due to proliferation, mobilization from
the bone marrow or spleen, or differentia-
tion remains to be determined. TheCD14+
CD16+ monocytes express CD138 and
CD169, surface markers of tissue sub-
capsular sinus macrophages, which in
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Previewsthe lymph node capture viruses from
tissues to present to B cells. The data
suggest that this CD14+CD16+ monocyte
population is capable of stimulating the
expansion of CD382+CD272+ plasma-
blasts following DENV infection through
the secretion of the cytokines BAFF,
APRIL, and IL-10. These data provide an
exciting new perspective into how the
innate immune response plays a role in
shaping the magnitude and quality of
the adaptive immune response; future
studies addressing the relation of these
findings with disease severity are now
warranted.
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